000 | 01959 a2200493 4500 | ||
---|---|---|---|
005 | 20250514045755.0 | ||
264 | 0 | _c20021204 | |
008 | 200212s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.212519699 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTumpey, Terrence M | |
245 | 0 | 0 |
_aExisting antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cOct 2002 |
||
300 |
_a13849-54 p. _bdigital |
||
500 | _aPublication Type: Historical Article; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAmantadine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
650 | 0 | 4 |
_aDisease Outbreaks _xhistory |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aGenes, Viral |
650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _xgenetics |
650 | 0 | 4 | _aHistory, 20th Century |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza A virus _xdrug effects |
650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aNeuraminidase _xantagonists & inhibitors |
650 | 0 | 4 | _aRecombination, Genetic |
650 | 0 | 4 |
_aRimantadine _xpharmacology |
650 | 0 | 4 |
_aViral Matrix Proteins _xgenetics |
650 | 0 | 4 |
_aVirulence _xgenetics |
700 | 1 | _aGarcĂa-Sastre, Adolfo | |
700 | 1 | _aMikulasova, Andrea | |
700 | 1 | _aTaubenberger, Jeffery K | |
700 | 1 | _aSwayne, David E | |
700 | 1 | _aPalese, Peter | |
700 | 1 | _aBasler, Christopher F | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 99 _gno. 21 _gp. 13849-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.212519699 _zAvailable from publisher's website |
999 |
_c12178558 _d12178558 |